← FDA Drug Approvals (Drugs@FDA)
NELARABINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SHORLA · Approved 2023-03-03
Drug application
- FDA Application #
ANDA214809- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NELARABINE
- Generic name
- NELARABINE
- Active ingredients
- NELARABINE
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- SHORLA
- Manufacturer
- Shorla Oncology Inc.
- First approval
- 2023-03-03
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown